Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 2—February 2021

Role of Burkholderia pseudomallei–Specific IgG2 in Adults with Acute Melioidosis, Thailand

Panjaporn Chaichana, Kemajittra Jenjaroen, Suchintana Chumseng, Manutsanun Sumonwiriya, Patpong Rongkard, Barbara Kronsteiner, Prapit Teparrukkul, Direk Limmathurotsakul, Nicholas P.J. Day, Narisara Chantratita, and Susanna J DunachieComments to Author 
Author affiliations: Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand (P. Chaichana, K. Jenjaroen, S. Chumseng, M. Sumonwiriya, P. Rongkard, D. Limmathurotsakul, N.P.J. Day, N. Chantratita, S.J. Dunachie); University of Oxford, Oxford, England (P. Rongkard, B. Kronsteiner, D. Limmathurotsakul, N.P.J. Day, S. Dunachie); Sunpasithiprasong Hospital, Ubon Ratchathani, Thailand (P. Teparrukkul)

Main Article

Table 2

Multivariable-adjusted logistic regression for melioidosis mortality rates, Thailand*

Variable Mortality rate
Adjusted OR (95% CI) p value
Serum IgG2 level 0.50 (0.30–0.83) 0.007
Age >45 y 0.36 (0.10–1.30) 0.120
Diabetes 0.92 (0.34–2.53) 0.876
Preexisting renal disease
9.41 (2.48–35.80)
Neutrophil count/µL
>4,000–8,000 Referent <0.001
<4,000 4.66 (0.52–41.50)
>8,000–12,000 19.00 (3.40–106.33)
14.78 (2.78–78.73)

*OR, odds ratio.

Main Article

Page created: December 14, 2020
Page updated: January 23, 2021
Page reviewed: January 23, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.